Company has never stated Ropren antiviral--Rebetron is not competition--Ropren will be prescribed in conjunction with Interferon etc. to deal with Hep C-- a huge international problem --What other comparitor do you think could have been used rather than Essentiale or perhaps St. Marys in trials?--re- Bio R's superior efficacy.There just isn't!
- Forums
- ASX - By Stock
- SLA
- interesting reaserch on solagran
interesting reaserch on solagran, page-19
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online